Clinigen Group (CLIN) Stock Discussion | Share discussion

Clinigen Group

Clinigen Group plc provides specialty pharmaceutical products and services in the United Kingdom and internationally.

Industry: Pharmaceuticals & Biotechnology

Ticker	Exchange	ISIN
$CLIN	LSE AIM	GB00B89J2419

Recent news

Carnival Net Income dropped on 442% and Revenue dropped on 73.1%

Unisys Corp reports 4,465% Net Income growth in 2020 while 31.3% Revenue decline

Northamber Net Income surged on 1,523%

International Bus Mach Corp reports 40.7% Net Income decline in 2020 and 3.2 pp EBITDA Margin decline from 20.7% to 17.5%

Blue Prism Group plc revenue surged on 40% and EBITDA Margin surged on 28.9 pp from -78.3% to -49.4%

Tui Ag EBITDA dropped on 220% and Revenue dropped on 58.0%

Zytronic Net Income dropped on 111% and EBITDA Margin dropped on 15.0 pp from 20.6% to 5.6%

Image Scan Hldgs revenue surged on 47.3% and EBITDA Margin surged on 21.0 pp from -16.0% to 5.0%

Oxford Metrics Net Income dropped on 61.6% and Revenue dropped on 14.3%

I-Nexus Global Plc revenue dropped on 14.3%

Twit about CLIN stock

Share your investment idea or question on Clinigen Group stock:

Latest twits on Clinigen Group (CLIN)

No twits yet. Be the first to post!

Have a question about CLIN? Ask and other investors will be eager to help you.

Have an idea about CLIN? Share it with other investors.

Clinigen Group news

17 Sep 2020 Clinigen Group EBITDA jumped on 49.0% and EBITDA Margin increased on 5.1 pp from 14.5% to 19.5%

Clinigen Group stock price chart

Clinigen Group financials

mln. £	FY2015	FY2016	FY2017

Revenue	184.4	339.9	302.3
EBITDA	39.245	41.000	64.000
Net income	5.685	13.500	3.800
CAPEX	0.200	1.300	1.400
Debt	104.0	95.900	62.800
Cash	27.800	27.800	27.800

Clinigen Group news

17 Sep 2020 Clinigen Group EBITDA jumped on 49.0% and EBITDA Margin increased on 5.1 pp from 14.5% to 19.5%

About Clinigen Group

Clinigen Group plc provides specialty pharmaceutical products and services in the United Kingdom and internationally. The company